A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189 in Healthy Adults 18 to 30 Years of Age
ModernaTX, Inc.
ModernaTX, Inc.
Harbinger Health
Lepu Biopharma Co., Ltd.
Protara Therapeutics
Shanghai Henlius Biotech
Dong-A ST Co., Ltd.
GlaxoSmithKline
D3 Bio (Wuxi) Co., Ltd
UCB Pharma
Astellas Pharma Inc
Novartis
Pfizer
Biocon Limited
ImmunityBio, Inc.
Shanghai Henlius Biotech
AstraZeneca
Eli Lilly and Company
Regeneron Pharmaceuticals
Hoffmann-La Roche
Compass Therapeutics
Boehringer Ingelheim
Shanghai JMT-Bio Inc.
Beijing Bio-Targeting Therapeutics Technology Co., Ltd
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
WestVac Biopharma Co., Ltd.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
On Target Laboratories, LLC
Biocity Biopharmaceutics Co., Ltd.
Prelude Therapeutics
AstraZeneca
Pfizer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
iLeukon Therapeutics, Inc.
Antev Ltd.
Puma Biotechnology, Inc.
Coherence Neuro Australia Pty Limited
Qilu Pharmaceutical Co., Ltd.
Novartis
Brainlab AG
Gan & Lee Pharmaceuticals.
FindCure Biosciences (ZhongShan) Co., Ltd.
3D Medicines
GlaxoSmithKline
Qilu Pharmaceutical Co., Ltd.
Relmada Therapeutics, Inc.
Hansoh BioMedical R&D Company
Tetragon Biosciences Ltd
UCB Pharma
Gilead Sciences
Hoffmann-La Roche